These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies. Holme AM; Roland MC; Henriksen T; Michelsen TM Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620 [TBL] [Abstract][Full Text] [Related]
23. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction. Herraiz I; Quezada MS; Rodriguez-Calvo J; Gómez-Montes E; Villalaín C; Galindo A Ultrasound Obstet Gynecol; 2018 Nov; 52(5):631-638. PubMed ID: 28876491 [TBL] [Abstract][Full Text] [Related]
24. An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia. Stolz M; Zeisler H; Heinzl F; Binder J; Farr A Pregnancy Hypertens; 2018 Jan; 11():54-60. PubMed ID: 29523274 [TBL] [Abstract][Full Text] [Related]
25. Prediction of adverse maternal outcomes of early severe preeclampsia. Mirkovic L; Tulic I; Stankovic S; Soldatovic I Pregnancy Hypertens; 2020 Oct; 22():144-150. PubMed ID: 32979729 [TBL] [Abstract][Full Text] [Related]
26. sFlt-1 to PlGF ratio cut-offs to predict adverse pregnancy outcomes in early-onset FGR and SGA: a prospective observational study. Bonacina E; Armengol-Alsina M; Hurtado I; Garcia-Manau P; Ferrer-Oliveras R; Monreal S; Pancorbo M; Mendoza M; Carreras E J Obstet Gynaecol; 2022 Oct; 42(7):2840-2845. PubMed ID: 35980876 [TBL] [Abstract][Full Text] [Related]
27. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension? Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863 [TBL] [Abstract][Full Text] [Related]
28. The sFlt-1/PlGF ratio values within the <38, 38-85 and >85 brackets as compared to perinatal outcomes. Bednarek-Jędrzejek M; Kwiatkowski S; Ksel-Hryciów J; Tousty P; Nurek K; Kwiatkowska E; Cymbaluk-Płoska A; Torbé A J Perinat Med; 2019 Sep; 47(7):732-740. PubMed ID: 31339858 [TBL] [Abstract][Full Text] [Related]
29. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies. Dröge L; Herraìz I; Zeisler H; Schlembach D; Stepan H; Küssel L; Henrich W; Galindo A; Verlohren S Ultrasound Obstet Gynecol; 2015 Mar; 45(3):286-93. PubMed ID: 25491901 [TBL] [Abstract][Full Text] [Related]
30. Addition of N-terminal pro-B natriuretic peptide to soluble fms-like tyrosine kinase-1/placental growth factor ratio > 38 improves prediction of pre-eclampsia requiring delivery within 1 week: a longitudinal cohort study. Sabriá E; Lequerica-Fernández P; Lafuente-Ganuza P; Eguia-Ángeles E; Escudero AI; Martínez-Morillo E; Barceló C; Álvarez FV Ultrasound Obstet Gynecol; 2018 Jun; 51(6):758-767. PubMed ID: 29498431 [TBL] [Abstract][Full Text] [Related]